PROPANC BIOPHARMA ADVANCES BIOANALYTICAL & IMMUNOGENICITY ASSAY DEVELOPMENT FOR PHASE 1B FIRST-IN-HUMAN STUDY IN UP TO 50 ADVANCED CANCER PATIENTS

Reuters · 1d ago

Please log in to view news